Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,413 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lutetium-177 PSMA radioligand therapy in taxan-naive first- and second-line metastatic castration resistant prostate cancer after first-line ARPI therapy.
Wenzel M, Hoeh B, Siech C, Koll F, Humke C, Groener D, Steuber T, Graefen M, Maurer T, Banek S, Chun FKH, Mandel P. Wenzel M, et al. Among authors: mandel p. Eur J Nucl Med Mol Imaging. 2025 Jan 13. doi: 10.1007/s00259-025-07076-7. Online ahead of print. Eur J Nucl Med Mol Imaging. 2025. PMID: 39804375
Robot-Assisted PSMA-Radioguided Salvage Surgery for Oligorecurrent Prostate Cancer Using the Novel SENSEI® Drop-in Gamma Probe: Correlation of Intraoperative Measurements to Preoperative Imaging and Final Histology.
Mazzucato G, Falkenbach F, Schmalhofer ML, Shenas F, Cerruto MA, Antonelli A, Tennstedt P, Graefen M, Preisser F, Mandel P, Knipper S, Budäus L, Koehler D, Maurer T. Mazzucato G, et al. Among authors: mandel p. Cancers (Basel). 2024 Dec 31;17(1):93. doi: 10.3390/cancers17010093. Cancers (Basel). 2024. PMID: 39796722 Free PMC article.
Critical Care Therapy After Cytoreductive Nephrectomy for Metastatic Kidney Cancer.
Siech C, de Angelis M, Jannello LMI, Di Bello F, Rodriguez Peñaranda N, Goyal JA, Tian Z, Saad F, Shariat SF, Puliatti S, Longo N, de Cobelli O, Briganti A, Hoeh B, Mandel P, Kluth LA, Chun FKH, Karakiewicz PI. Siech C, et al. Among authors: mandel p. Crit Care Med. 2025 Jan 1;53(1):e132-e139. doi: 10.1097/CCM.0000000000006496. Epub 2024 Nov 14. Crit Care Med. 2025. PMID: 39774205
Life expectancy in rare histological prostate cancer subtypes.
Siech C, de Angelis M, Jannello LMI, Di Bello F, Rodriguez Peñaranda N, Goyal JA, Tian Z, Saad F, Shariat SF, Puliatti S, Longo N, de Cobelli O, Briganti A, Wenzel M, Mandel P, Kluth LA, Chun FKH, Karakiewicz PI. Siech C, et al. Among authors: mandel p. Int J Cancer. 2024 Dec 30. doi: 10.1002/ijc.35323. Online ahead of print. Int J Cancer. 2024. PMID: 39740082
Administration and cancer-control outcomes of bone-modifying agents in real-world patients with metastatic castration-resistant prostate cancer.
Wenzel M, Hoeh B, Humke C, Welte M, Cano Garcia C, Siech C, Saad F, Karakiewcz PI, Tilki D, Steuber T, Graefen M, Traumann M, Chun FKH, Mandel P. Wenzel M, et al. Among authors: mandel p. JBMR Plus. 2024 Nov 26;9(1):ziae157. doi: 10.1093/jbmrpl/ziae157. eCollection 2025 Jan. JBMR Plus. 2024. PMID: 39677923 Free PMC article.
Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: An Updated Network Meta-analysis Including ARANOTE Data.
Hoeh B, Wenzel M, Tian Z, Karakiewicz PI, Saad F, Steuber T, Graefen M, Tilki D, Herout R, Thomas C, Chun FK, Mandel P. Hoeh B, et al. Among authors: mandel p. Eur Urol Focus. 2024 Dec 5:S2405-4569(24)00245-1. doi: 10.1016/j.euf.2024.11.004. Online ahead of print. Eur Urol Focus. 2024. PMID: 39643549 Free article.
Cancer-Control Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer With BRCA Gene or Tumor Suppressor Mutations Undergoing 177-Lutetium Prostate-Specific Membrane Antigen Radioligand Therapy.
Wenzel M, Koll F, Hoeh B, Humke C, Reis H, Wild P, Steuber T, Graefen M, Tilki D, Sabet A, Gröner D, Chun FKH, Mandel P. Wenzel M, et al. Among authors: mandel p. JCO Precis Oncol. 2024 Dec;8:e2400645. doi: 10.1200/PO-24-00645. Epub 2024 Dec 6. JCO Precis Oncol. 2024. PMID: 39642328
1,413 results